{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T09:31:33Z","timestamp":1790415093869,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd007522","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,6,21]],"date-time":"2018-06-21T00:00:00Z","timestamp":1529539200000}}],"reference-count":165,"publisher":"Wiley","issue":"6","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007522.pub2","type":"journal-article","created":{"date-parts":[[2018,6,21]],"date-time":"2018-06-21T21:17:00Z","timestamp":1529615820000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Pharmacological therapies for management of opium withdrawal"],"prefix":"10.1002","volume":"2018","author":[{"given":"Afarin","family":"Rahimi-Movaghar","sequence":"first","affiliation":[{"name":"Tehran University of Medical Sciences; Iranian National Center for Addiction Studies (INCAS); No. 486, South Karegar Ave. Tehran Tehran Iran 1336616357"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaleh","family":"Gholami","sequence":"additional","affiliation":[{"name":"Tehran University of Medical Sciences; Iranian National Center for Addiction Studies (INCAS); No. 486, South Karegar Ave. Tehran Tehran Iran 1336616357"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Amato","sequence":"additional","affiliation":[{"name":"Lazio Regional Health Service; Department of Epidemiology; Via Cristoforo Colombo, 112 Rome Italy 00154"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Hoseinie","sequence":"additional","affiliation":[{"name":"Tehran University of Medical Sciences; Iranian National Center for Addiction Studies (INCAS); No. 486, South Karegar Ave. Tehran Tehran Iran 1336616357"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Yousefi-Nooraie","sequence":"additional","affiliation":[{"name":"University of Toronto; Institute of Health Policy, Management and Evaluation; 155 College Street Toronto ON Canada M5T 3M6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoumeh","family":"Amin-Esmaeili","sequence":"additional","affiliation":[{"name":"Tehran University of Medical Sciences; Iranian National Center for Addiction Studies (INCAS); No. 486, South Karegar Ave. Tehran Tehran Iran 1336616357"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,6,21]]},"reference":[{"issue":"31","key":"10.1002\/14651858.CD007522.pub2-BIB0001|cit1","first-page":"26","article-title":"Baclofen and clonidine in opioid detoxification","volume":"8","author":"Ahmadi Abhari","year":"2003","journal-title":"Iranian Journal of Psychiatry and Clinical Psychology (Andeesheh Va Raftar)"},{"issue":"3","key":"10.1002\/14651858.CD007522.pub2-BIB0002|cit2","first-page":"142","article-title":"Amantadine as augmentation in managing opioid withdrawal with clonidine: a randomized controlled trial","volume":"9","author":"Amiri","year":"2014","journal-title":"Iranian Journal of Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD007522.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/j.1360-0443.2008.02248.x","article-title":"Effect of add-on gabapentin on opioid withdrawal symptoms in opium-dependent patients","volume":"103","author":"*Kheirabadi","year":"2008","journal-title":"Addiction"},{"issue":"10","key":"10.1002\/14651858.CD007522.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1111\/j.1360-0443.2009.02784.x","article-title":"\"Effect of add-on gabapentin on opioid withdrawal symptoms in opium-dependent patients\": Corrigendum","volume":"104","author":"Kheirabadi","year":"2009","journal-title":"Addiction"},{"issue":"6","key":"10.1002\/14651858.CD007522.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0376-8716(76)90004-1","article-title":"Experiences of a methadone detoxification programme for opium addicts","volume":"1","author":"Lal","year":"1976","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1002\/14651858.CD007522.pub2-BIB0006|cit6","first-page":"195","article-title":"Amitriptyline efficacy in control of acute opioid withdrawal syndrome","volume":"6","author":"Salehi","year":"2005","journal-title":"Koomesh, Journal of Semnan University of Medical Sciences"},{"issue":"3","key":"10.1002\/14651858.CD007522.pub2-BIB0007|cit7","first-page":"57","article-title":"A comparative study on opium withdrawal of buprenorphine and clonidine","volume":"11","author":"Salehi","year":"2007","journal-title":"Journal of Qazvin University of Medical Sciences"},{"issue":"1","key":"10.1002\/14651858.CD007522.pub2-BIB0008|cit8","first-page":"28","article-title":"Comparison of the efficacy of methadone and tramadol in opioid-assisted detoxification","volume":"33","author":"Salehi","year":"2007","journal-title":"Iranian Journal of Medical Sciences"},{"issue":"3","key":"10.1002\/14651858.CD007522.pub2-BIB0009|cit9","first-page":"185","article-title":"Tramadol versus methadone for the management of acute opioid withdrawal: an add-on study","volume":"11","author":"Salehi","year":"2006","journal-title":"Journal of Research in Medical Sciences"},{"issue":"1","key":"10.1002\/14651858.CD007522.pub2-BIB0010|cit10","first-page":"55","article-title":"A double blind comparative study of usefulness of clonidine and symptomatic therapy in opiate detoxication","volume":"30","author":"Satija","year":"1988","journal-title":"Indian Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD007522.pub2-BIB0011|cit11","first-page":"343","article-title":"A double blind comparative study of usefulness of diphenoxylate and propoxyphene napsylate in the withdrawal treatment of opium addicts","volume":"26","author":"Singh","year":"1984","journal-title":"Indian Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD007522.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/j.1365-2125.2008.03277.x","article-title":"Flexible dosing of tincture of opium in the management of opioid withdrawal: pharmacokinetics and pharmacodynamics","volume":"66","author":"Somogyi","year":"2008","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"1","key":"10.1002\/14651858.CD007522.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1080\/10550887.2015.1074504","article-title":"Opium tincture versus methadone syrup in management of acute raw opium withdrawal: a randomized, double-blind, controlled trial","volume":"35","author":"Tabassomi","year":"2016","journal-title":"Journal of Addictive Diseases"},{"issue":"3","key":"10.1002\/14651858.CD007522.pub2-BIB0014|cit14","first-page":"41","article-title":"A comparative study of effectiveness of two methods of detoxification in opium dependent patients","volume":"27","author":"Taraghi","year":"2005","journal-title":"Medical Journal of Tabriz University of Medical Sciences & Health Services"},{"issue":"3-4","key":"10.1002\/14651858.CD007522.pub2-BIB0015|cit15","first-page":"79","article-title":"Comparison of the efficacy of buprenorphine and clonidine in detoxification of opioid-dependents","volume":"4","author":"Ziaaddini","year":"2012","journal-title":"Addiction & Health"},{"issue":"5","key":"10.1002\/14651858.CD007522.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2710.2000.00295.x","article-title":"Double-blind randomized controlled trial of baclofen vs clonidine in the treatment of opiates withdrawal","volume":"25","author":"Akhondzadeh","year":"2000","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD007522.pub2-BIB0017|cit17","first-page":"163","article-title":"Role of clonidine in acute opioid abstinence syndrome","volume":"17","author":"Alam Ansari","year":"2001","journal-title":"Pakistan Journal of Medical Sciences"},{"issue":"3","key":"10.1002\/14651858.CD007522.pub2-BIB0018|cit18","first-page":"353","article-title":"Calcium channel blocker verapamil: a nonhormonal option for hot flashes management in patients with acute opioid abstinence syndrome","volume":"23","author":"Ansari","year":"2007","journal-title":"Pakistan Journal of Medical Sciences"},{"issue":"1","key":"10.1002\/14651858.CD007522.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jsat.2004.05.002","article-title":"Opioid detoxification using high doses of buprenorphine in 24 hours: a randomized, double blind, controlled clinical trial","volume":"27","author":"Assadi","year":"2004","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"3","key":"10.1002\/14651858.CD007522.pub2-BIB0020|cit20","first-page":"195","article-title":"High dose of buprenorphine in one-day opium detoxification: clinical trial","volume":"10","author":"Hafezi","year":"2005","journal-title":"Iranian Journal of Psychiatry and Clinical Psychology (Andeesheh Va Raftar)"},{"issue":"3","key":"10.1002\/14651858.CD007522.pub2-BIB0021|cit21","first-page":"203","article-title":"Rapid and clonidine detoxification in opium dependent patients","volume":"10","author":"Badiei","year":"2005","journal-title":"Iranian Journal of Psychiatry and Clinical Psychology (Andeesheh Va Raftar)"},{"issue":"1-2","key":"10.1002\/14651858.CD007522.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0376-8716(96)01289-6","article-title":"Randomised double-blind comparison of lofexidine and methadone in the in-patient treatment of opiate withdrawal","volume":"43","author":"Bearn","year":"1996","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1002\/14651858.CD007522.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/13556210020040226","article-title":"The impact of naloxone\/lofexidine combination treatment on the opiate withdrawal syndrome","volume":"6","author":"Bearn","year":"2001","journal-title":"Addiction Biology"},{"issue":"2","key":"10.1002\/14651858.CD007522.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/105504901750227778","article-title":"Gradual dose taper following chronic buprenorphine","volume":"10","author":"Becker","year":"2001","journal-title":"American Journal on Addictions"},{"issue":"5","key":"10.1002\/14651858.CD007522.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1006\/phrs.1997.0170","article-title":"The association carbamazepine-mianserin in opiate withdrawal: a double blind pilot study versus clonidine","volume":"35","author":"Bertschy","year":"1997","journal-title":"Pharmacological Research"},{"issue":"4","key":"10.1002\/14651858.CD007522.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1521-0391.2003.tb00544.x","article-title":"The effectiveness of combined naloxone\/lofexidine in opiate detoxification: results from a double-blind randomized and placebo-controlled trial","volume":"12","author":"Beswick","year":"2003","journal-title":"American Journal on Addictions"},{"issue":"4","key":"10.1002\/14651858.CD007522.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1176\/ajp.154.4.584a","article-title":"Opiate withdrawal with dextromethorphan","volume":"154","author":"Bisaga","year":"1997","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD007522.pub2-BIB0028|cit28","first-page":"181","article-title":"Rapid opiate detoxification and naltrexone induction under general anaesthesia and assisted ventilation: experiences with 510 patients in four different centres","volume":"98","author":"Brewer","year":"1998","journal-title":"Acta Psychiatrica Belgica"},{"issue":"7341","key":"10.1002\/14651858.CD007522.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/S0140-6736(64)91922-1","article-title":"Amiphenazole in the treatment of morphine and opium addiction","volume":"1","author":"Bruce","year":"1964","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD007522.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0376-8716(99)00116-7","article-title":"Naltrexone and lofexidine combination treatment compared with conventional lofexidine treatment for in-patient opiate detoxification","volume":"59","author":"Buntwal","year":"2000","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1002\/14651858.CD007522.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0376-8716(98)00040-4","article-title":"Randomised double-blind comparison of lofexidine and clonidine in the out-patient treatment of opiate withdrawal","volume":"50","author":"Carnwath","year":"1998","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1002\/14651858.CD007522.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s002130000628","article-title":"Effects of methadone on cognition, mood and craving in detoxifying opiate addicts: a dose-response study","volume":"154","author":"Curran","year":"2001","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD007522.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1360-0443.2004.00959.x","article-title":"General anaesthesia does not improve outcome in opioid antagonist detoxification treatment: a randomized controlled trial","volume":"100","author":"Jong","year":"2005","journal-title":"Addiction"},{"key":"10.1002\/14651858.CD007522.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.drugalcdep.2015.02.033","article-title":"Characterizing opioid withdrawal during double-blind buprenorphine detoxification","volume":"151","author":"Dunn","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1002\/14651858.CD007522.pub2-BIB0035|cit35","first-page":"214","article-title":"Rapid detoxification of opium dependent patients via opioid antagonist","volume":"10","author":"Eftekhar","year":"2005","journal-title":"Iranian Journal of Psychiatry and Clinical Psychology (Andeesheh Va Raftar)"},{"issue":"1","key":"10.1002\/14651858.CD007522.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1080\/00952990.2016.1210614","article-title":"Palonosetron and hydroxyzine pre-treatment reduces the objective signs of experimentally-induced acute opioid withdrawal in humans: a double-blinded, randomized, placebo-controlled crossover study","volume":"43","author":"Erlendson","year":"2017","journal-title":"American Journal of Drug and Alcohol Abuse"},{"issue":"6","key":"10.1002\/14651858.CD007522.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0210-5691(01)79689-1","article-title":"Study of an ultrashort opiate detoxification protocol in an intensive care unit: preliminary results","volume":"25","author":"Espinosa Berenguel","year":"2001","journal-title":"Medicina Intensiva"},{"issue":"2","key":"10.1002\/14651858.CD007522.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.drugalcdep.2005.06.003","article-title":"Opioid antagonist detoxification under anaesthesia versus traditional clonidine detoxification combined with an additional week of psychosocial support: a randomised clinical trial","volume":"81","author":"Favrat","year":"2006","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1002\/14651858.CD007522.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/08897070109511459","article-title":"A comparison of clonidine and buprenorphine in the outpatient treatment of opiate withdrawal","volume":"22","author":"Fingerhood","year":"2001","journal-title":"Substance Abuse"},{"issue":"48","key":"10.1002\/14651858.CD007522.pub2-BIB0040|cit40","first-page":"2117","article-title":"Voluntary detoxification therapy of young drug addicts in a medical clinic","volume":"116","author":"Friess","year":"1974","journal-title":"MMW - Munchener Medizinische Wochenschrift"},{"issue":"2","key":"10.1002\/14651858.CD007522.pub2-BIB0041|cit41","first-page":"186","article-title":"Abrupt withdrawal of buprenorphine following chronic administration","volume":"45","author":"Fudala","year":"1989","journal-title":"Clinical Pharmacology & Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD007522.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0376-8716(98)00008-8","article-title":"Effects of buprenorphine and naloxone in morphine-stabilized opioid addicts","volume":"50","author":"Fudala","year":"1998","journal-title":"Drug and Alcohol Dependence"},{"issue":"10","key":"10.1002\/14651858.CD007522.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1056\/NEJMoa022164","article-title":"Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone","volume":"349","author":"Fudala","year":"2003","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD007522.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1176\/ajp.137.3.375","article-title":"Effect of methadone dosage on clonidine detoxification efficacy","volume":"137","author":"Gold","year":"1980","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD007522.pub2-BIB0045|cit45","first-page":"95","article-title":"Clinical utility of clonidine in opiate withdrawal","volume":"34","author":"Gold","year":"1981","journal-title":"NIDA Research Monograph"},{"key":"10.1002\/14651858.CD007522.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1016\/j.drugalcdep.2014.09.256","article-title":"Memantine improves buprenorphine treatment for opioid-dependent young adults","volume":"146","author":"Gonzalez","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"issue":"6539","key":"10.1002\/14651858.CD007522.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1136\/bmj.293.6539.103","article-title":"Opiate withdrawal: inpatient versus outpatient programmes and preferred versus random assignment to treatment","volume":"293","author":"Gossop","year":"1986","journal-title":"British Medical Journal (Clinical Research Ed)"},{"issue":"1-3","key":"10.1002\/14651858.CD007522.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.drugalcdep.2007.11.021","article-title":"A randomized trial of 6-month methadone maintenance with standard or minimal counseling versus 21-day methadone detoxification","volume":"94","author":"Gruber","year":"2008","journal-title":"Drug and Alcohol Dependence"},{"issue":"5","key":"10.1002\/14651858.CD007522.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.addbeh.2010.01.001","article-title":"Unobserved versus observed office buprenorphine\/naloxone induction: a pilot randomized clinical trial","volume":"35","author":"Gunderson","year":"2010","journal-title":"Addictive Behaviors"},{"issue":"2","key":"10.1002\/14651858.CD007522.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0376-8716(02)00024-8","article-title":"Prison based detoxification for opioid dependence: a randomised double blind controlled trial of lofexidine and methadone","volume":"67","author":"Howells","year":"2002","journal-title":"Drug and Alcohol Dependence"},{"issue":"12","key":"10.1002\/14651858.CD007522.pub2-BIB0051|cit51","first-page":"1011","article-title":"Safety and effectiveness of opiate antagonist detoxification under general anesthesia","volume":"41","author":"Ivaskevicius","year":"2005","journal-title":"Medicina (Kaunas)"},{"issue":"7","key":"10.1002\/14651858.CD007522.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1046\/j.1360-0443.2002.00196.x","article-title":"Nimodipine in opiate detoxification: a controlled trial","volume":"97","author":"Jimenez-Lerma","year":"2002","journal-title":"Addiction"},{"issue":"5","key":"10.1002\/14651858.CD007522.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1365-2125.2004.02209.x","article-title":"Comparison of tincture of opium and methadone to control opioid withdrawal in a Thai treatment centre","volume":"58","author":"Jittiwutikarn","year":"2004","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"1","key":"10.1002\/14651858.CD007522.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0376-8716(95)01186-2","article-title":"A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence","volume":"40","author":"Johnson","year":"1995","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1002\/14651858.CD007522.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0376-8716(95)01189-7","article-title":"Buprenorphine treatment of opioid dependence: clinical trial of daily versus alternate-day dosing","volume":"40","author":"Johnson","year":"1995","journal-title":"Drug and Alcohol Dependence"},{"issue":"8","key":"10.1002\/14651858.CD007522.pub2-BIB0056|cit56","first-page":"625","article-title":"Effects of ketamine on precipitated opiate withdrawal","volume":"42","author":"Jovaisa","year":"2006","journal-title":"Medicina (Kaunas)"},{"key":"10.1002\/14651858.CD007522.pub2-BIB0057|cit57","first-page":"S116","article-title":"Gabapentin in the treatment of opioid withdrawal","volume":"21","author":"Kheirabadi","year":"2011","journal-title":"Klinik Psikofarmakoloji Bulteni"},{"issue":"4","key":"10.1002\/14651858.CD007522.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/00003246-200004000-00010","article-title":"Acute detoxification of opioid-addicted patients with naloxone during propofol or methohexital anesthesia: a comparison of withdrawal symptoms, neuroendocrine, metabolic, and cardiovascular patterns","volume":"28","author":"Kienbaum","year":"2000","journal-title":"Critical Care Medicine"},{"issue":"7","key":"10.1002\/14651858.CD007522.pub2-BIB0059|cit59","first-page":"692","article-title":"A randomized trial of intramuscular olanzapine versus oral clonidine for symptomatic treatment of opioid withdrawal in the emergency department","volume":"55","author":"Klein","year":"2017","journal-title":"Clinical Toxicology"},{"issue":"5","key":"10.1002\/14651858.CD007522.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0010-440X(84)90049-X","article-title":"Relationship of depression to clonidine detoxification of opiate addicts","volume":"25","author":"Kosten","year":"1984","journal-title":"Comprehensive Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD007522.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/0024-3205(88)90454-7","article-title":"Buprenorphine detoxification from opioid dependence: a pilot study","volume":"42","author":"Kosten","year":"1988","journal-title":"Life Sciences"},{"issue":"10","key":"10.1002\/14651858.CD007522.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1176\/ajp.146.10.1349a","article-title":"Rapid detoxification from opioid dependence","volume":"146","author":"Kosten","year":"1989","journal-title":"American Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD007522.pub2-BIB0063|cit63","first-page":"296","article-title":"From Modinos' cure to lecithin treatment: detoxification and withdrawal management in the state-sponsored mass treatment scheme for opium addicts in Assam, 1938-39","volume":"25","author":"Kour","year":"2012","journal-title":"National Medical Journal of India"},{"issue":"8","key":"10.1002\/14651858.CD007522.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1001\/jamainternmed.2014.2556","article-title":"Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial","volume":"174","author":"Liebschutz","year":"2014","journal-title":"JAMA Internal Medicine"},{"issue":"8","key":"10.1002\/14651858.CD007522.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/j.1360-0443.2005.01154.x","article-title":"A multi-center randomized trial of buprenorphine-naloxone versus clonidine for opioid detoxification: findings from the National Institute on Drug Abuse Clinical Trials Network","volume":"100","author":"Ling","year":"2005","journal-title":"Addiction"},{"issue":"2","key":"10.1002\/14651858.CD007522.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1360-0443.2008.02455.x","article-title":"Buprenorphine tapering schedule and illicit opioid use","volume":"104","author":"Ling","year":"2009","journal-title":"Addiction"},{"issue":"3","key":"10.1002\/14651858.CD007522.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00213-007-0847-3","article-title":"Modest opioid withdrawal suppression efficacy of oral tramadol in humans","volume":"194","author":"Lofwall","year":"2007","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD007522.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3109\/00952999109027554","article-title":"Similar efficacy of abrupt and gradual opiate detoxification","volume":"17","author":"Loimer","year":"1991","journal-title":"American Journal of Drug and Alcohol Abuse"},{"issue":"5","key":"10.1002\/14651858.CD007522.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1176\/ajp.150.5.839a","article-title":"Ultrashort noninvasive opiate detoxification","volume":"150","author":"Loimer","year":"1993","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD007522.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000259168","article-title":"Clonidine versus withdrawal using an opioid in inpatient opioid detoxification","volume":"3","author":"Malhotra","year":"1997","journal-title":"European Addiction Research"},{"issue":"2","key":"10.1002\/14651858.CD007522.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1369-1600.2008.00119.x","article-title":"Very low dose naltrexone addition in opioid detoxification: a randomized, controlled trial","volume":"14","author":"Mannelli","year":"2009","journal-title":"Addiction Biology"},{"issue":"2","key":"10.1002\/14651858.CD007522.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/10550490902772785","article-title":"Early outcomes following low dose naltrexone enhancement of opioid detoxification","volume":"18","author":"Mannelli","year":"2009","journal-title":"American Journal on Addictions"},{"issue":"10","key":"10.1002\/14651858.CD007522.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1001\/archpsyc.62.10.1157","article-title":"Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial","volume":"62","author":"Marsch","year":"2005","journal-title":"Archives of General Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD007522.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.drugalcdep.2006.09.020","article-title":"In-patient detoxification procedures, treatment retention, and post-treatment opiate use: comparison of lofexidine plus naloxone, lofexidine plus placebo, and methadone","volume":"88","author":"McCambridge","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1002\/14651858.CD007522.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s002130050804","article-title":"Buprenorphine and naloxone combinations: the effects of three dose ratios in morphine-stabilized, opiate-dependent volunteers","volume":"141","author":"Mendelson","year":"1999","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD007522.pub2-BIB0076|cit76","first-page":"215","article-title":"The effect of gabapentin on withdrawal syndrome, psychiatric disorders and electroencephalogram of opium addicts during the detoxification period","volume":"3","author":"Mobasher","year":"2004","journal-title":"Iranian Journal of Pharmaceutical Research"},{"issue":"5","key":"10.1002\/14651858.CD007522.pub2-BIB0077|cit77","first-page":"985","article-title":"The effects of gabapentin on methadone based addiction treatment: a randomized controlled trial","volume":"26","author":"Moghadam","year":"2013","journal-title":"Pakistan Journal of Pharmaceutical Sciences"},{"issue":"2","key":"10.1002\/14651858.CD007522.pub2-BIB0078|cit78","first-page":"131","article-title":"Inpatient medically supervised opioid withdrawal, with buprenorphine alone and in combination with naltrexone","volume":"55","author":"Montoya","year":"1994","journal-title":"Clinical Pharmacology & Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD007522.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.psychres.2004.07.012","article-title":"Effect of intravenous magnesium sulphate in reducing irritability and restlessness in pure and polysubstance opiate detoxification","volume":"135","author":"Naderi-Heiden","year":"2005","journal-title":"Psychiatry Research"},{"issue":"5","key":"10.1002\/14651858.CD007522.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"337","DOI":"10.5055\/jom.2011.0074","article-title":"Ultra-rapid opiate detoxification using dexmedetomidine under general anesthesia","volume":"7","author":"Nasr","year":"2011","journal-title":"Journal of Opioid Management"},{"issue":"4","key":"10.1002\/14651858.CD007522.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0740-5472(93)90024-V","article-title":"Buprenorphine in opiate withdrawal: a comparison with clonidine","volume":"10","author":"Nigam","year":"1993","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"5","key":"10.1002\/14651858.CD007522.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1007\/BF02599459","article-title":"Ambulatory opiate detoxification and primary care: a role for the primary care physician","volume":"7","author":"O'Connor","year":"1992","journal-title":"Journal of General Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD007522.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF02599882","article-title":"Primary care-based ambulatory opioid detoxification: the results of a clinical trial","volume":"10","author":"O'Connor","year":"1995","journal-title":"Journal of General Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD007522.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1521-0391.1998.tb00346.x","article-title":"Effect of LAAM dose on opiate use in opioid-dependent patients: a pilot study","volume":"7","author":"Oliveto","year":"1998","journal-title":"American Journal on Addictions"},{"issue":"4","key":"10.1002\/14651858.CD007522.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1521-0391.1994.tb00247.x","article-title":"Buprenorphine stabilization and rapid-taper protocol for the detoxification of opioid-dependent patients","volume":"3","author":"Parran","year":"1994","journal-title":"American Journal on Addictions"},{"issue":"3","key":"10.1002\/14651858.CD007522.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0376-8716(99)00122-2","article-title":"A controlled trial of daily versus thrice-weekly buprenorphine administration for the treatment of opioid dependence","volume":"59","author":"Perez de los Cobos","year":"2000","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1002\/14651858.CD007522.pub2-BIB0087|cit87","first-page":"289","article-title":"Buprenorphine: pilot trials in borderline patients and opiate dependence - treatment of a common disorder?","volume":"81","author":"Resnick","year":"1988","journal-title":"NIDA Research Monograph"},{"issue":"8177","key":"10.1002\/14651858.CD007522.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0140-6736(80)91516-0","article-title":"Rapid opiate detoxification with clonidine and naloxone","volume":"1","author":"Riordan","year":"1980","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD007522.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0893-133X(95)00087-T","article-title":"The effect of gamma-hydroxybutyric acid on naloxone-precipitated opiate withdrawal","volume":"14","author":"Rosen","year":"1996","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD007522.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00005053-198502000-00007","article-title":"Success and failure at outpatient opioid detoxification, evaluating the process of clonidine- and methadone-assisted withdrawal","volume":"173","author":"Rounsaville","year":"1985","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD007522.pub2-BIB0091|cit91","first-page":"455","article-title":"Double blind assessment of buprenorphine withdrawal in opiate-addicts","volume":"105","author":"Sam","year":"1990","journal-title":"NIDA Research Monograph Series"},{"issue":"4","key":"10.1002\/14651858.CD007522.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1037\/a0033724","article-title":"Randomized, placebo-controlled pilot trial of gabapentin during an outpatient, buprenorphine-assisted detoxification procedure","volume":"21","author":"Sanders","year":"2013","journal-title":"Experimental and Clinical Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD007522.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/13556210500123191","article-title":"Mood and affect during detoxification of opiate addicts: a comparison of buprenorphine versus methadone","volume":"10","author":"Seifert","year":"2005","journal-title":"Addiction Biology"},{"key":"10.1002\/14651858.CD007522.pub2-BIB0094|cit94","unstructured":"Senay E Tennant FS Washton AM Boehringer Ingelheim GmbH report number U85-0844 Boehringer Ingelheim Pty Ltd 1983"},{"key":"10.1002\/14651858.CD007522.pub2-BIB0095|cit95","first-page":"309","article-title":"Three methods of ambulatory opiate detoxification: preliminary results of a randomized clinical trial","volume":"132","author":"Shi","year":"1993","journal-title":"NIDA Research Monograph Series"},{"issue":"4","key":"10.1002\/14651858.CD007522.pub2-BIB0096|cit96","first-page":"297","article-title":"N-acetyl cysteine effect on life quality of morphine addicts in treatment period: a pilot study","volume":"13","author":"Shohrati","year":"2009","journal-title":"Kowsar Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD007522.pub2-BIB0097|cit97","first-page":"197","article-title":"N-acetyl cysteine effect on sleep quality and respiratory function of morphine addicts in treatment period: a pilot study","volume":"11","author":"Shohrati","year":"2010","journal-title":"Journal of Military Medicine"},{"issue":"11","key":"10.1002\/14651858.CD007522.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1111\/j.1360-0443.2004.00834.x","article-title":"Evaluation of an injection depot formulation of buprenorphine: placebo comparison","volume":"99","author":"Sigmon","year":"2004","journal-title":"Addiction"},{"issue":"4","key":"10.1002\/14651858.CD007522.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00213-006-0640-8","article-title":"Effects of lofexidine on stress-induced and cue-induced opioid craving and opioid abstinence rates: preliminary findings","volume":"190","author":"Sinha","year":"2007","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD007522.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s002130050626","article-title":"Effects of dynorphin A(1-13) on opiate withdrawal in humans","volume":"137","author":"Specker","year":"1998","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD007522.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1600-0447.1998.tb09993.x","article-title":"Lorazepam in the treatment of opiate-withdrawal insomnia: a randomized double-blind study","volume":"97","author":"Srisurapanont","year":"1998","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"3","key":"10.1002\/14651858.CD007522.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/clpt.2010.352","article-title":"Induction of opioid-dependent individuals onto buprenorphine and buprenorphine\/naloxone soluble-films","volume":"89","author":"Strain","year":"2011","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"6","key":"10.1002\/14651858.CD007522.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/0306-4603(90)90054-2","article-title":"Comparison of linear versus inverse exponential methadone reduction curves in the detoxification of opiate addicts","volume":"15","author":"Strang","year":"1990","journal-title":"Addictive Behaviors"},{"issue":"2","key":"10.1002\/14651858.CD007522.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000456612","article-title":"Randomised comparison of a novel buprenorphine oral lyophilisate versus existing buprenorphine sublingual tablets in opioid-dependent patients: a first-in-patient phase II randomised open label safety study","volume":"23","author":"Strang","year":"2017","journal-title":"European Addiction Research"},{"issue":"11","key":"10.1002\/14651858.CD007522.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.jaac.2011.07.010","article-title":"Predictors of abstinence: National Institute of Drug Abuse multisite buprenorphine\/naloxone treatment trial in opioid-dependent youth","volume":"50","author":"Subramaniam","year":"2011","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD007522.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1176\/appi.ajp.2016.16050548","article-title":"Long-acting injectable naltrexone induction: a randomized trial of outpatient opioid detoxification with naltrexone versus buprenorphine","volume":"174","author":"Sullivan","year":"2017","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD007522.pub2-BIB0107|cit107","first-page":"441","article-title":"Buprenorphine-ketorolac vs. clonidine-naproxen in the withdrawal from opioids","volume":"4","author":"Telias","year":"2000","journal-title":"International Journal of Psychosocial Rehabilitation"},{"issue":"3","key":"10.1002\/14651858.CD007522.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0376-8716(99)00033-2","article-title":"Naltrexone shortened opioid detoxification with buprenorphine","volume":"56","author":"Umbricht","year":"1999","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1002\/14651858.CD007522.pub2-BIB0109|cit109","first-page":"117","article-title":"Opioid detoxification with buprenorphine alone or in combination with naltrexone","volume":"162","author":"Umbricht-Schneiter","year":"1996","journal-title":"NIDA Research Monograph"},{"issue":"5","key":"10.1002\/14651858.CD007522.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1360-0443.1988.tb02576.x","article-title":"Clinical utility of rapid clonidine-naltrexone detoxification for opioid abusers","volume":"83","author":"Vining","year":"1988","journal-title":"British Journal of Addiction"},{"issue":"4","key":"10.1002\/14651858.CD007522.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1360-0443.2003.00372.x","article-title":"Evaluation of the effects of lofexidine and clonidine on naloxone-precipitated withdrawal in opioid-dependent humans","volume":"98","author":"Walsh","year":"2003","journal-title":"Addiction"},{"key":"10.1002\/14651858.CD007522.pub2-BIB0112|cit112","first-page":"114","article-title":"Double-blind controlled detoxification from buprenorphine","volume":"162","author":"Wang","year":"1996","journal-title":"NIDA Research Monograph"},{"key":"10.1002\/14651858.CD007522.pub2-BIB0113|cit113","first-page":"233","article-title":"Clonidine hydrochloride: a non opiate treatment for opiate withdrawal","volume":"27","author":"Washton","year":"1979","journal-title":"NIDA Research Monograph"},{"issue":"8207","key":"10.1002\/14651858.CD007522.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/S0140-6736(80)92356-9","article-title":"Clonidine versus methadone for opiate detoxification","volume":"2","author":"Washton","year":"1980","journal-title":"Lancet (London, England)"},{"key":"10.1002\/14651858.CD007522.pub2-BIB0115|cit115","first-page":"89","article-title":"Clonidine vs. methadone for opiate detoxification: double-blind outpatient trials","volume":"34","author":"Washton","year":"1981","journal-title":"NIDA Research Monograph"},{"issue":"1","key":"10.1002\/14651858.CD007522.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0376-8716(01)00149-1","article-title":"Two methods of community detoxification from opiates: an open-label comparison of lofexidine and buprenorphine","volume":"65","author":"White","year":"2001","journal-title":"Drug and Alcohol Dependence"},{"issue":"10","key":"10.1002\/14651858.CD007522.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1016\/j.addbeh.2013.05.015","article-title":"Concordance between self-report and urine drug screen data in adolescent opioid dependent clinical trial participants","volume":"38","author":"Wilcox","year":"2013","journal-title":"Addictive Behaviors"},{"issue":"6","key":"10.1002\/14651858.CD007522.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0740-5472(93)90056-8","article-title":"Methadone combined with clonidine versus clonidine alone in opiate detoxification","volume":"10","author":"Wilson","year":"1993","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"17","key":"10.1002\/14651858.CD007522.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.2008.574","article-title":"Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial","volume":"300","author":"Woody","year":"2008","journal-title":"JAMA"},{"issue":"393","key":"10.1002\/14651858.CD007522.pub2-BIB0120|cit120","first-page":"217","article-title":"Lofexidine based regimen for opiate addicts","volume":"45","author":"Wylie","year":"1995","journal-title":"British Journal of General Practice"},{"issue":"1-2","key":"10.1002\/14651858.CD007522.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.drugalcdep.2008.04.002","article-title":"A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal","volume":"97","author":"Yu","year":"2008","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1002\/14651858.CD007522.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1080\/10550887.2012.665728","article-title":"Tramadol versus methadone for treatment of opiate withdrawal: a double-blind, randomized, clinical trial","volume":"31","author":"Zarghami","year":"2012","journal-title":"Journal of Addictive Diseases"},{"issue":"2","key":"10.1002\/14651858.CD007522.pub2-BIB0123|cit123","first-page":"63","article-title":"Comparing symptoms of withdrawal, rapid detoxification and detoxification with clonidine in drug dependent patients","volume":"1","author":"Ziaaddini","year":"2009","journal-title":"Addiction & Health"},{"issue":"1","key":"10.1002\/14651858.CD007522.pub2-BIB0124|cit124","first-page":"1","article-title":"Trial of tramadol plus gabapentin for opioid detoxification","volume":"17","author":"Ziaaddini","year":"2015","journal-title":"Iranian Red Crescent Medical Journal"},{"issue":"1-3","key":"10.1002\/14651858.CD007522.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.drugalcdep.2008.06.016","article-title":"Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine-naloxone and clonidine in the NIDA clinical trials network drug and alcohol dependence","volume":"99","author":"Ziedonis","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"issue":"5","key":"10.1002\/14651858.CD007522.pub2-BIB0126|cit126","first-page":"109","article-title":"New combined treatment for opioid detoxification: the association between dextropropoxyphene and guanfacine","volume":"22","author":"Huertas","year":"1995","journal-title":"Revista de Psiquiatria de la Facultad de Medicina de Barcelona"},{"issue":"2","key":"10.1002\/14651858.CD007522.pub2-BIB0127|cit127","first-page":"167","article-title":"A comparison of buprenorphine to clonidine for rapid inpatient opiate detoxification","volume":"51","author":"Johnson","year":"1992","journal-title":"Clinical Pharmacology & Therapeutics"},{"issue":"23","key":"10.1002\/14651858.CD007522.pub2-BIB0128|cit128","first-page":"3586","article-title":"Random double blind test study of detoxicated effect of Kangfuxin, Fukangpian & clonidine hydrochloride on opiate withdrawal syndromes","volume":"6","author":"Kang","year":"2002","journal-title":"Chinese Journal of Clinical Rehabilitation"},{"key":"10.1002\/14651858.CD007522.pub2-BIB0129|cit129","first-page":"368","article-title":"Very low-dose naltrexone versus placebo in alleviating withdrawal manifestation","volume":"52","author":"Rezaiyan","year":"2014","journal-title":"Clinical Toxicology"},{"issue":"4","key":"10.1002\/14651858.CD007522.pub2-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1024\/2008.04.03","article-title":"Methadone versus buprenorphine for inpatient detoxification treatment","volume":"54","author":"Steinmann","year":"2008","journal-title":"Sucht"},{"key":"10.1002\/14651858.CD007522.pub2-BIB0131|cit131","volume-title":"Afghanistan drug use survey 2005: Executive summary","author":"Afghanistan Ministry of Counter Narcotics & United Nations Office on Drugs and Crime","year":"2005"},{"issue":"1","key":"10.1002\/14651858.CD007522.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0740-5472(03)00141-7","article-title":"Twelve-month maintenance treatment of opium-dependent patients","volume":"26","author":"Ahmadi","year":"2004","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2","key":"10.1002\/14651858.CD007522.pub2-BIB0133|cit133","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003409.pub4","article-title":"Methadone at tapered doses for the management of opioid withdrawal","author":"Amato","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007522.pub2-BIB0134|cit134","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1111\/add.13453","article-title":"Epidemiology of illicit drug use disorders in Iran: prevalence, correlates, comorbidity and service utilization, results from the Iranian mental health survey","volume":"111","author":"Amin-Esmaeili","year":"2016","journal-title":"Addiction"},{"key":"10.1002\/14651858.CD007522.pub2-BIB0135|cit135","volume-title":"Goodman and Gilman's The Pharmacological Basis of Therapeutics","author":"Brunton","year":"2006"},{"key":"10.1002\/14651858.CD007522.pub2-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1186\/1471-2458-13-325","article-title":"Correlates of opium use: retrospective analysis of a survey of tribal communities in Arunachal Pradesh, India","volume":"13","author":"Chaturvedi","year":"2013","journal-title":"BMC Public Health"},{"key":"10.1002\/14651858.CD007522.pub2-BIB0137|cit137","first-page":"20","article-title":"Comparative evaluation of psychiatric disorders in opium and heroin dependent patients","volume":"1(1)","author":"Ghaffarnejad","year":"2009","journal-title":"Addiction and Health"},{"issue":"3","key":"10.1002\/14651858.CD007522.pub2-BIB0138|cit138","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002025.pub4","article-title":"Buprenorphine for the management of opioid withdrawal","author":"Gowing","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD007522.pub2-BIB0139|cit139","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002021.pub3","article-title":"Opioid antagonists with minimal sedation for opioid withdrawal","author":"Gowing","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD007522.pub2-BIB0140|cit140","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002022.pub3","article-title":"Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal","author":"Gowing","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD007522.pub2-BIB0141|cit141","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002024.pub4","article-title":"Alpha2-adrenergic agonists for the management of opioid withdrawal","author":"Gowing","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"19","key":"10.1002\/14651858.CD007522.pub2-BIB0142|cit142","first-page":"1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Oxman","year":"2004","journal-title":"BMJ"},{"issue":"7560","key":"10.1002\/14651858.CD007522.pub2-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD007522.pub2-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines 1. Introduction - GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD007522.pub2-BIB0145|cit145","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD007522.pub2-BIB0146|cit146","unstructured":"Iranian MoH Epidemiologic study of drug abuse in Iran. Tehran Iranian Ministry of Health 2002"},{"issue":"1","key":"10.1002\/14651858.CD007522.pub2-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/16066350902825930","article-title":"A follow-up study of drug users in Southern Iran","volume":"18","author":"Jafari","year":"2010","journal-title":"Addiction Research & Theory"},{"key":"10.1002\/14651858.CD007522.pub2-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/14659891.2015.1130181","article-title":"Determination of opium abuse prevalence in Iranian young people: a systematic review and meta-analysis","volume":"22","author":"Menati","year":"2017","journal-title":"Journal of Substance Use"},{"key":"10.1002\/14651858.CD007522.pub2-BIB0149|cit149","unstructured":"PubChem Thebaine PubChem Substance and Compound databases 2008"},{"key":"10.1002\/14651858.CD007522.pub2-BIB0150|cit150","first-page":"83","article-title":"Drug use situation in university students in Iran: a literature review","volume":"5","author":"Rahimi-Movaghar","year":"2006","journal-title":"Payesh [Health Monitor]"},{"issue":"1","key":"10.1002\/14651858.CD007522.pub2-BIB0151|cit151","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007775.pub2","article-title":"Pharmacological therapies for maintenance treatments of opium dependence","author":"Rahimi-Movaghar","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3-4","key":"10.1002\/14651858.CD007522.pub2-BIB0152|cit152","first-page":"99","article-title":"A scientometric study of Iranian scientific productions in the field of substance use and addiction research in the years 2008 to 2012","volume":"7","author":"Rahimi-Movaghar","year":"2015","journal-title":"Addiction & Health"},{"key":"10.1002\/14651858.CD007522.pub2-BIB0153|cit153","volume-title":"The extent, pattern and trends of drug abuse in India: national survey","author":"Ray","year":"2004"},{"key":"10.1002\/14651858.CD007522.pub2-BIB0154|cit154","volume-title":"Opium abuse and its management: global scenario","author":"Ray","year":"2006"},{"key":"10.1002\/14651858.CD007522.pub2-BIB0155|cit155","first-page":"18","volume-title":"Rapid situation assessment of drug abuse in Iran","author":"Razaghi","year":"1999"},{"key":"10.1002\/14651858.CD007522.pub2-BIB0156|cit156","unstructured":"The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"5","key":"10.1002\/14651858.CD007522.pub2-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1164\/rccm.200602-197ST","article-title":"An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations","volume":"174","author":"Sch\u00fcnemann","year":"2006","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD007522.pub2-BIB0158|cit158","volume-title":"Martindale: The Complete Drug Reference","author":"Sweetman","year":"2007"},{"key":"10.1002\/14651858.CD007522.pub2-BIB0159|cit159","unstructured":"United Nations Office on Drugs and Crime Drug use in Afghanistan 2009 survey: executive summary www.unodc.org\/documents\/data-and-analysis\/Studies\/Afghan-Drug-Survey-2009-Executive-Summary-web.pdf"},{"key":"10.1002\/14651858.CD007522.pub2-BIB0160|cit160","doi-asserted-by":"crossref","DOI":"10.18356\/e04aa9e2-en","volume-title":"World Drug Report 2011","author":"United Nations Office on Drugs and Crime","year":"2011"},{"issue":"5","key":"10.1002\/14651858.CD007522.pub2-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/00005053-197705000-00007","article-title":"Opium and heroin addicts in Laos. II. A study of matched pairs","volume":"164","author":"Westermeyer","year":"1977","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD007522.pub2-BIB0162|cit162","unstructured":"World Health Organization Regional Office for the Eastern Mediterranean A draft of the 5-year regional strategic planning on substance abuse, 2005-2009 2004"},{"key":"10.1002\/14651858.CD007522.pub2-BIB0163|cit163","volume-title":"Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence","author":"World Health Organization","year":"2009"},{"issue":"3","key":"10.1002\/14651858.CD007522.pub2-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0021-5198(19)52850-5","article-title":"Thebaine metabolites in the urine of rhesus monkeys","volume":"31","author":"Yamazoe","year":"1981","journal-title":"Japanese Journal of Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD007522.pub2-BIB0165|cit165","first-page":"1","article-title":"Is methadone substitution the best treatment of choice for opioid dependence?","volume":"2","author":"Zarghami","year":"2008","journal-title":"Iranian Journal of Psychiatry and Behavioral Sciences"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD007522.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T07:36:21Z","timestamp":1751700981000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD007522.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Drugs and Alcohol Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,6,21]]},"references-count":165,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007522.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,21]]}}}